Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

Clinical trial NCT00062491 · COMPLETED

Trial details

NCT number: NCT00062491
Sponsor: BioNumerik Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Neoplasm

Start date: 2002-05-01
Primary completion: 2003-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.